{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:13:20Z","timestamp":1791929600559,"version":"4.3.4"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12879-018-3525-7","type":"journal-article","created":{"date-parts":[[2018,12,7]],"date-time":"2018-12-07T07:18:51Z","timestamp":1544167131000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Seroprevalence of antibodies to primate erythroparvovirus 1 (B19V) in Australia"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3446-8248","authenticated-orcid":false,"given":"Helen M.","family":"Faddy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise C.","family":"Gorman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica C.","family":"Hoad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca D.","family":"Frentiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Tozer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. L. P.","family":"Flower","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,7]]},"reference":[{"issue":"4","key":"3525_CR1","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/S0955-3886(97)00049-0","volume":"18","author":"M Letaief","year":"1997","unstructured":"Letaief M, Vanham G, Boukef K, Yacoub S, Muylle L, Mertens G. Higher prevalence of parvovirus B19 in Belgian as compared to Tunisian blood donors: differential implications for prevention of transfusional transmission. Transfus Sci. 1997;18(4):523\u201330.","journal-title":"Transfus Sci"},{"issue":"3","key":"3525_CR2","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1017\/S0950268899003817","volume":"124","author":"HA Kelly","year":"2000","unstructured":"Kelly HA, Siebert D, Hammond R, Leydon J, Kiely P, Maskill W. The age-specific prevalence of human parvovirus immunity in Victoria, Australia compared with other parts of the world. Epidemiol Infect. 2000;124(3):449\u201357.","journal-title":"Epidemiol Infect"},{"issue":"3","key":"3525_CR3","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1128\/CMR.15.3.485-505.2002","volume":"15","author":"ED Heegaard","year":"2002","unstructured":"Heegaard ED, Brown KE. Human Parvovirus B19. Clin Microbiol Rev. 2002;15(3):485\u2013505.","journal-title":"Clin Microbiol Rev"},{"issue":"6","key":"3525_CR4","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1590\/0074-02760150261","volume":"110","author":"LC Conteville","year":"2015","unstructured":"Conteville LC, Zanella L, Marin MA, Filippis AM, Nogueira RM, Vicente AC, Mendonca MC. Parvovirus B19 1A complete genome from a fatal case in Brazil. Mem Inst Oswaldo Cruz. 2015;110(6):820\u20131.","journal-title":"Mem Inst Oswaldo Cruz."},{"issue":"6","key":"3525_CR5","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1159\/000322190","volume":"37","author":"J Bl\u00fcmel","year":"2010","unstructured":"Bl\u00fcmel J, Burger R, Drosten C, Gr\u00f6ner A, G\u00fcrtler L, Heiden M, Hildebrandt M, Jansen B, Montag-Lessing T, Offergeld R, et al. Parvovirus B19 \u2013 Revised. Transfus Med Hemother. 2010;37(6):339\u201350.","journal-title":"Transfus Med Hemother"},{"issue":"5130","key":"3525_CR6","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1126\/science.8211117","volume":"262","author":"KE Brown","year":"1993","unstructured":"Brown KE, Anderson SM, Young NS. Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science (New York, NY). 1993;262(5130):114\u20137.","journal-title":"Science (New York, NY)"},{"issue":"10","key":"3525_CR7","doi-asserted-by":"publisher","first-page":"3530","DOI":"10.1172\/JCI41805","volume":"120","author":"Z Wan","year":"2010","unstructured":"Wan Z, Zhi N, Wong S, Keyvanfar K, Liu D, Raghavachari N, Munson PJ, Su S, Malide D, Kajigaya S, et al. Human parvovirus B19 causes cell cycle arrest of human erythroid progenitors via deregulation of the E2F family of transcription factors. J Clin Invest. 2010;120(10):3530\u201344.","journal-title":"J Clin Invest"},{"issue":"2","key":"3525_CR8","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/j.1471-0528.2010.02749.x","volume":"118","author":"RF Lamont","year":"2011","unstructured":"Lamont RF, Sobel J, Vaisbuch E, Kusanovic JP, Mazaki-Tovi S, Kim SK, Uldbjerg N, Romero R. Parvovirus B19 infection in human pregnancy. BJOG Int J Obstet Gynaecol. 2011;118(2):175\u201386.","journal-title":"BJOG Int J Obstet Gynaecol"},{"issue":"12","key":"3525_CR9","doi-asserted-by":"publisher","first-page":"3927","DOI":"10.1182\/blood-2003-05-1522","volume":"102","author":"KA Weigel-Kelley","year":"2003","unstructured":"Weigel-Kelley KA, Yoder MC, Srivastava A. \u03b15\u03b21 integrin as a cellular coreceptor for human parvovirus B19: requirement of functional activation of \u03b21 integrin for viral entry. Blood. 2003;102(12):3927\u201333.","journal-title":"Blood"},{"issue":"2","key":"3525_CR10","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1086\/505226","volume":"194","author":"S Doyle","year":"2006","unstructured":"Doyle S, Corcoran A. The immune response to parvovirus B19 exposure in previously seronegative and seropositive individuals. J Infect Dis. 2006;194(2):154\u20138.","journal-title":"J Infect Dis"},{"issue":"s4","key":"3525_CR11","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/ajt.12111","volume":"13","author":"AJ Eid","year":"2013","unstructured":"Eid AJ, Chen SF, ASTIDCoP. Human parvovirus B19 in solid organ transplantation. Am J Transplant. 2013;13(s4):201\u20135.","journal-title":"Am J Transplant"},{"key":"3525_CR12","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3389\/fmed.2018.00004","volume":"5","author":"D Juhl","year":"2018","unstructured":"Juhl D, Hennig H. Parvovirus B19: what is the relevance in transfusion medicine? Front Med (Lausanne). 2018;5:4.","journal-title":"Front Med (Lausanne)."},{"issue":"3","key":"3525_CR13","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1093\/infdis\/154.3.383","volume":"154","author":"T Chorba","year":"1986","unstructured":"Chorba T, Coccia P, Holman RC, Tattersall P, Anderson LJ, Sudman J, Young NS, Kurczynski E, Saarinen UM, Moir R, et al. The role of parvovirus B19 in aplastic crisis and erythema Infectiosum (fifth disease). J Infect Dis. 1986;154(3):383\u201393.","journal-title":"J Infect Dis"},{"issue":"2","key":"3525_CR14","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1086\/505082","volume":"194","author":"J Wildig","year":"2006","unstructured":"Wildig J, Michon P, Siba P, Mellombo M, Ura A, Mueller I, Cossart Y. Parvovirus B19 infection contributes to severe Anemia in young children in Papua New Guinea. J Infect Dis. 2006;194(2):146\u201353.","journal-title":"J Infect Dis"},{"issue":"2","key":"3525_CR15","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1093\/infdis\/152.2.257","volume":"152","author":"MJ Anderson","year":"1985","unstructured":"Anderson MJ, Higgins PG, Davis LR, Willman JS, Jones SE, Kidd IM, Pattison JR, Tyrrell DAJ. Experimental Parvoviral infection in humans. J Infect Dis. 1985;152(2):257\u201365.","journal-title":"J Infect Dis"},{"issue":"4","key":"3525_CR16","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s100670070046","volume":"19","author":"HD Stahl","year":"2000","unstructured":"Stahl HD, Seidl B, Hubner B, Altrichter S, Pfeiffer R, Pustowoit B, Liebert UG, Hofmann J, von Salis-Soglio G, Emmrich F. High incidence of parvovirus B19 DNA in synovial tissue of patients with undifferentiated mono- and oligoarthritis. Clin Rheumatol. 2000;19(4):281\u20136.","journal-title":"Clin Rheumatol"},{"issue":"5","key":"3525_CR17","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1001\/archinte.1989.00390050111022","volume":"149","author":"AD Woolf","year":"1989","unstructured":"Woolf AD, Campion GV, Chishick A, et al. Clinical manifestations of human parvovirus b19 in adults. Arch Intern Med. 1989;149(5):1153\u20136.","journal-title":"Arch Intern Med"},{"issue":"8426","key":"3525_CR18","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/S0140-6736(85)91146-8","volume":"1","author":"DM Reid","year":"1985","unstructured":"Reid DM, Reid TM, Brown T, Rennie JA, Eastmond CJ. Human parvovirus-associated arthritis: a clinical and laboratory description. Lancet. 1985;1(8426):422\u20135.","journal-title":"Lancet"},{"issue":"8426","key":"3525_CR19","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S0140-6736(85)91145-6","volume":"1","author":"DG White","year":"1985","unstructured":"White DG, Woolf AD, Mortimer PP, Cohen BJ, Blake DR, Bacon PA. Human parvovirus arthropathy. Lancet. 1985;1(8426):419\u201321.","journal-title":"Lancet"},{"issue":"2","key":"3525_CR20","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/j.1471-0528.1998.tb10048.x","volume":"105","author":"E Miller","year":"1998","unstructured":"Miller E, Fairley CK, Cohen BJ, Seng C. Immediate and long term outcome of human parvovirus B19 infection in pregnancy. Br J Obstet Gynaecol. 1998;105(2):174\u20138.","journal-title":"Br J Obstet Gynaecol"},{"issue":"9","key":"3525_CR21","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1111\/j.1537-2995.2010.03047.x","volume":"51","author":"M Satake","year":"2011","unstructured":"Satake M, Hoshi Y, Taira R, Momose SY, Hino S, Tadokoro K. Symptomatic parvovirus B19 infection caused by blood component transfusion. Transfusion. 2011;51(9):1887\u201395.","journal-title":"Transfusion"},{"issue":"1","key":"3525_CR22","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1128\/CMR.00040-16","volume":"30","author":"J Qiu","year":"2017","unstructured":"Qiu J, Soderlund-Venermo M, Young NS. Human Parvoviruses. Clin Microbiol Rev. 2017;30(1):43\u2013113.","journal-title":"Clin Microbiol Rev"},{"issue":"12","key":"3525_CR23","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1086\/599042","volume":"48","author":"M Douvoyiannis","year":"2009","unstructured":"Douvoyiannis M, Litman N, Goldman DL. Neurologic manifestations associated with parvovirus B19 infection. Clin Infect Dis. 2009;48(12):1713\u201323.","journal-title":"Clin Infect Dis."},{"issue":"4","key":"3525_CR24","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/j.1365-3148.2007.00765.x","volume":"17","author":"A Parsyan","year":"2007","unstructured":"Parsyan A, Candotti D. Human erythrovirus B19 and blood transfusion \u2013 an update. Transfus Med. 2007;17(4):263\u201378.","journal-title":"Transfus Med"},{"issue":"11","key":"3525_CR25","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1017\/S0950268807009958","volume":"136","author":"C R\u00f6hrer","year":"2008","unstructured":"R\u00f6hrer C, G\u00e4rtner B, Sauerbrei A, B\u00f6hm S, Hottentr\u00e4ger B, Raab U, Thierfelder W, Wutzler P, Modrow S. Seroprevalence of parvovirus B19 in the German population. Epidemiol Infect. 2008;136(11):1564\u201375.","journal-title":"Epidemiol Infect."},{"key":"3525_CR26","unstructured":"OpenEpi: Open Source Epidemiological Statistics for Public Health. \n                    www.openepi.com\n                    \n                  ."},{"issue":"7","key":"3525_CR27","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/vox.12559","volume":"112","author":"VC Hoad","year":"2017","unstructured":"Hoad VC, Seed CR, Fryk JJ, Harley R, Flower RLP, Hogema BM, Kiely P, Faddy HM. Hepatitis E virus RNA in Australian blood donors: prevalence and risk assessment. Vox Sang. 2017;112(7):614\u201321.","journal-title":"Vox Sang"},{"issue":"3","key":"3525_CR28","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/apm.12127","volume":"122","author":"F de Ory","year":"2014","unstructured":"de Ory F, Minguito T, Echevarria JE, Del Mar Mosquera M, Fuertes A. Comparative evaluation of tests for detection of parvovirus B19 IgG and IgM. APMIS. 2014;122(3):223\u20139.","journal-title":"APMIS"},{"key":"3525_CR29","volume-title":"Introduction to the theory of Statistics","author":"AM Mood","year":"1950","unstructured":"Mood AM. Introduction to the theory of Statistics; 1950."},{"key":"3525_CR30","unstructured":"Australian Bureau of Statistics. \n                    https:\/\/guest.censusdata.abs.gov.au\/webapi\/jsf\/tableView\/tableView.xhtml\n                    \n                  ."},{"key":"3525_CR31","unstructured":"Pregnancy -info.net. \n                    http:\/\/www.pregnancy-Infonet\/childbirth-history\/childbearing.html\n                    \n                  ."},{"issue":"4","key":"3525_CR32","first-page":"161","volume":"16","author":"S Munoz","year":"1998","unstructured":"Munoz S, Alonso M, Fernandez M, Munoz J, Garcia-Rodriguez J. Seroprevalence versus Parvovirus B19 in blood donors. Enferm Infecc Microbiol Clin. 1998;16(4):161\u20132.","journal-title":"Enferm Infecc Microbiol Clin."},{"issue":"10","key":"3525_CR33","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1002\/jmv.23358","volume":"84","author":"SN Slavov","year":"2012","unstructured":"Slavov SN, Haddad SK, Silva-Pinto AC, Amarilla AA, Alfonso HL, Aquino VH, Covas DT. Molecular and phylogenetic analyses of human parvovirus B19 isolated from Brazilian patients with sickle cell disease and [beta]-thalassemia major and healthy blood donors. J Med Virol. 2012;84(10):1652.","journal-title":"J Med Virol"},{"issue":"12","key":"3525_CR34","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1007\/s00705-013-1746-z","volume":"158","author":"T Ihara","year":"2013","unstructured":"Ihara T, Furusyo N, Hayashi T, Toyoda K, Murata M, Hayashi J. A population-based epidemiological survey of human parvovirus B19 infection: a project of the Kyushu and Okinawa population study (KOPS). Arch Virol. 2013;158(12):2465\u201372.","journal-title":"Arch Virol"},{"key":"3525_CR35","unstructured":"Flower R, Gorman E, Hoad V, Frentiu F, Tozer S, Bialasiewicz S, Faddy H. Variation in parvovirus B19 IgG seroprevalence between different states in Australia. In: Australian Society for Microbiology Annual Scientific Meeting 2018. Brisbane; 2018. Available from: \n                    http:\/\/asmicro-2018.p.asnevents.com.au\/days\/2018-07-01\/abstract\/53004\n                    \n                  ."},{"issue":"3","key":"3525_CR36","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1055\/s-0037-1614507","volume":"81","author":"AM Eis-H\u00fcbinger","year":"1999","unstructured":"Eis-H\u00fcbinger AM, Sasowski U, Brackmann HH. Parvovirus B19 DNA contamination in coagulation factor VIII products. Thromb Haemost. 1999;81(3):476\u20137.","journal-title":"Thromb Haemost"},{"issue":"9","key":"3525_CR37","first-page":"R104","volume":"4","author":"NJ Gay","year":"1994","unstructured":"Gay NJ, Hesketh LM, Cohen BJ, Rush M, Bates C, Morgan-Capner P, Miller E. Age specific antibody prevalence to parvovirus B19: how many women are infected in pregnancy? Commun Dis Rep CDR Rev. 1994;4(9):R104\u20137.","journal-title":"Commun Dis Rep CDR Rev"},{"issue":"1","key":"3525_CR38","first-page":"7","volume":"66","author":"P Grabarczyk","year":"2012","unstructured":"Grabarczyk P, Korzeniowska J, Liszewski G, Kalinska A, Sulkowska E, Krug-Janiak M, Kopacz A, Letowska M, Brojer E. Parvovirus B19 DNA testing in polish blood donors, 2004-2010. Przegl Epidemiol. 2012;66(1):7\u201312.","journal-title":"Przegl Epidemiol."},{"issue":"5","key":"3525_CR39","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1111\/j.1471-0528.2000.tb13306.x","volume":"107","author":"IP Jensen","year":"2000","unstructured":"Jensen IP, Thorsen P, Jeune B, Moller BR, Vestergaard BF. An epidemic of parvovirus B19 in a population of 3,596 pregnant women: a study of sociodemographic and medical risk factors. BJOG. 2000;107(5):637\u201343.","journal-title":"BJOG"},{"issue":"4","key":"3525_CR40","first-page":"344","volume":"7","author":"SJ Knowles","year":"2004","unstructured":"Knowles SJ, Grundy K, Cahill I, Cafferkey MT. Susceptibility to infectious rash illness in pregnant women from diverse geographical regions. Commun Dis Public Health. 2004;7(4):344\u20138.","journal-title":"Commun Dis Public Health"},{"issue":"1\u20132","key":"3525_CR41","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ejogrb.2005.11.042","volume":"128","author":"PH van Gessel","year":"2006","unstructured":"van Gessel PH, Gaytant MA, Vossen AC, Galama JM, Ursem NT, Steegers EA, Wildschut HI. Incidence of parvovirus B19 infection among an unselected population of pregnant women in the Netherlands: a prospective study. Eur J Obstet Gynecol Reprod Biol. 2006;128(1\u20132):46\u20139.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"2","key":"3525_CR42","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1017\/S0950268804003474","volume":"133","author":"NL Gilbert","year":"2005","unstructured":"Gilbert NL, Gyorkos TW, Beliveau C, Rahme E, Muecke C, Soto JC. Seroprevalence of parvovirus B19 infection in daycare educators. Epidemiol Infect. 2005;133(2):299\u2013304.","journal-title":"Epidemiol Infect"},{"issue":"4","key":"3525_CR43","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1017\/S095026880600731X","volume":"135","author":"M Enders","year":"2007","unstructured":"Enders M, Weidner A, Enders G. Current epidemiological aspects of human parvovirus B19 infection during pregnancy and childhood in the western part of Germany. Epidemiol Infect. 2007;135(4):563\u20139.","journal-title":"Epidemiol Infect"},{"issue":"2","key":"3525_CR44","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/(SICI)1096-9071(199902)57:2<169::AID-JMV14>3.0.CO;2-1","volume":"57","author":"KH Lin","year":"1999","unstructured":"Lin KH, You SL, Chen CJ, Wang CF, Yang CS, Yamazaki S. Seroepidemiology of human parvovirus B19 in Taiwan. J Med Virol. 1999;57(2):169\u201373.","journal-title":"J Med Virol"},{"issue":"3","key":"3525_CR45","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1017\/S0950268800068552","volume":"113","author":"Y Matsunaga","year":"1994","unstructured":"Matsunaga Y, Goh KT, Utagawa E, Muroi N. Low prevalence of antibody to human parvovirus B19 in Singapore. Epidemiol Infect. 1994;113(3):537\u201340.","journal-title":"Epidemiol Infect"},{"issue":"7","key":"3525_CR46","first-page":"505","volume":"83","author":"BD Schoub","year":"1993","unstructured":"Schoub BD, Blackburn NK, Johnson S, McAnerney JM. Primary and secondary infection with human parvovirus B19 in pregnant women in South Africa. S Afr Med J. 1993;83(7):505\u20136.","journal-title":"S Afr Med J."},{"issue":"9","key":"3525_CR47","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1111\/j.1537-2995.2011.03067.x","volume":"51","author":"L Ke","year":"2011","unstructured":"Ke L, He M, Li C, Liu Y, Gao L, Yao F, Li J, Bi X, Lv Y, Wang J, et al. The prevalence of human parvovirus B19 DNA and antibodies in blood donors from four Chinese blood centers. Transfusion. 2011;51(9):1909\u201318.","journal-title":"Transfusion"},{"key":"3525_CR48","doi-asserted-by":"publisher","first-page":"9647675","DOI":"10.1155\/2016\/9647675","volume":"2016","author":"AC Shrestha","year":"2016","unstructured":"Shrestha AC, Flower RL, Seed CR, Stramer SL, Faddy HM. A comparative study of assay performance of commercial hepatitis E virus enzyme-linked immunosorbent assay kits in Australian blood donor samples. J Blood Transfus. 2016;2016:9647675.","journal-title":"J Blood Transfus."},{"issue":"3","key":"3525_CR49","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/j.1423-0410.1995.tb02595.x","volume":"69","author":"M Tsujimura","year":"1995","unstructured":"Tsujimura M, Matsushita K, Shiraki H, Sato H, Okochi K, Maeda Y. Human parvovirus B19 infection in blood donors. Vox Sang. 1995;69(3):206\u201312.","journal-title":"Vox Sang"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-3525-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-018-3525-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-3525-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,6]],"date-time":"2019-12-06T19:06:36Z","timestamp":1575659196000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-018-3525-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["3525"],"URL":"https:\/\/doi.org\/10.1186\/s12879-018-3525-7","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"8 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"For blood donor samples, ethical approval was obtained from the Blood Service Human Research Ethics Committee, and blood donors provided written consent for their sample to be used for research purposes. For paediatric samples, ethical approval was obtained from the Children\u2019s Health Queensland Ethics Committee. A waiver to consent paediatric individuals was provided, and approved by the aforementioned committee, as samples were sourced from patients presenting for non-infectious investigations such that it was not possible to obtain specific consent for inclusion in this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Francesca D Frentiu is a member of the editorial board (Associate Editor) of this journal. All other authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"631"}}